Results 321 to 330 of about 4,732,777 (361)
Some of the next articles are maybe not open access.
Neoadjuvant therapy for resectable melanoma
Clinical & Experimental MetastasisThe standard of care for patients with resectable stage III/IV melanoma classically included upfront resection with adjuvant therapy. However, in more recent years, the amount of systemic therapies available for neoadjuvant use for these patients has increased.
Cimarron E. Sharon +1 more
openaire +2 more sources
[Resectable colorectal liver metastases: pro neoadjuvant therapy - contra neoadjuvant therapy].
Zeitschrift fur Gastroenterologie, 2011Approximately one third of patients with colorectal cancer (CRC) present with metastases confined to the liver only. In 15 % of these patients the metastases are primarily resectable. After resection of colorectal liver metastases the 5-year survival rate is 25 - 40 %. The EORTC trial of Nordlinger et al.
D, Arnold +5 more
openaire +1 more source
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Ca-A Cancer Journal for Clinicians, 2021Kyle Wang
exaly
Future direction of total neoadjuvant therapy for locally advanced rectal cancer
Nature reviews: Gastroenterology & hepatologyY. Kagawa +16 more
semanticscholar +1 more source

